McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
45,000
Employees45,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
45,000
Employees45,000

MCK Key Statistics

Market cap
100.68B
Market cap100.68B
Price-Earnings ratio
25.39
Price-Earnings ratio25.39
Dividend yield
0.36%
Dividend yield0.36%
Average volume
907.63K
Average volume907.63K
High today
$819.53
High today$819.53
Low today
$807.83
Low today$807.83
Open price
$813.88
Open price$813.88
Volume
715.69K
Volume715.69K
52 Week high
$895.58
52 Week high$895.58
52 Week low
$558.13
52 Week low$558.13

Stock Snapshot

As of today, McKesson(MCK) shares are valued at $810.26. The company's market cap stands at 100.68B, with a P/E ratio of 25.39 and a dividend yield of 36.2%.

On 2025-12-12, McKesson(MCK) stock moved within a range of $807.83 to $819.53. With shares now at $810.26, the stock is trading +0.3% above its intraday low and -1.1% below the session's peak.

Trading activity shows a volume of 715.69K, compared to an average daily volume of 907.63K.

Over the past 52 weeks, McKesson(MCK) stock has traded between a high of $895.58 and a low of $558.13.

Over the past 52 weeks, McKesson(MCK) stock has traded between a high of $895.58 and a low of $558.13.

MCK News

TipRanks 2d
McKesson price target raised to $904 from $861 at Deutsche Bank

Deutsche Bank analyst George Hill raised the firm’s price target on McKesson (MCK) to $904 from $861 and keeps a Buy rating on the shares. The company reiterate...

Simply Wall St 5d
Is McKesson’s ORLYNVAH Distribution Deal a Small Step or a Bigger Strategy Signal?

In late November 2025, Iterum Therapeutics announced that its oral antibiotic ORLYNVAH became available through McKesson’s specialty distribution channel, enabl...

Is McKesson’s ORLYNVAH Distribution Deal a Small Step or a Bigger Strategy Signal?
Simply Wall St 6d
McKesson: Revisiting Valuation After a Recent Pullback in a Longer-Term Uptrend

McKesson (MCK) has quietly pulled back about 8% over the past week and 4% over the past month, even though the stock is still up roughly 18% in the past 3 month...

McKesson: Revisiting Valuation After a Recent Pullback in a Longer-Term Uptrend

Analyst ratings

80%

of 20 ratings
Buy
80%
Hold
15%
Sell
5%

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.